Divisions
DrugsWell’s diverse divisions unite specialized expertise, robust manufacturing, and patient-centric innovation to offer a portfolio that spans cutting-edge APIs, finished formulations, generics, biologics, and end-to-end services—all underpinned by stringent quality and regulatory standards.
1. Active Pharmaceutical Ingredients (API) Division
Leveraging state-of-the-art WHO-GMP and ISO-certified facilities, DrugsWell’s API Division produces high-purity molecules that serve as the foundation for our finished products.
Small-molecule APIs for neuro, cardiovascular, gastroenterology, and musculoskeletal therapies
Anti-infective and analgesic API manufacturing
Custom API synthesis (e.g., neurologic agent backbones for Rejubion QL and Amitrion-25)
Rigorous quality control and regulatory compliance
2. Formulations Division
Our Formulations Division transforms APIs into patient-ready dosage forms with optimal bioavailability.
Oral tablets and capsules (Tolipace SR 450, Tolipace 150)
Injectable formulations for acute care
Syrups (Rejubion Syrup) and complex dispersible granules (Rejubion CD3)
Topical preparations and specialized delivery systems (Palmiwell-NXT pain gel)
3. Generic Medicines Division
Affordability meets quality in our Generics Division, making proven therapies accessible:
High-quality generics for neuropathic pain (Rejubion QL, Amitrion-25), vertigo & migraine (Mirlivert-16, Emilysis MD), and more
Comprehensive bioequivalence testing for rapid market entry
Cost-effective formulations for broad therapeutic coverage
4. Therapeutic Specialties Division
Focused divisions ensure deep clinical expertise and tailored support:
Neurology & Psychiatry
Flagship neuropathic pain treatments (Rejubion QL, Amitrion-25)
Anticonvulsants, cognition enhancers, and anti-depressants
Vertigo relief (Mirlivert-16) and migraine management (Emilysis MD)
Pain Management & Orthopaedics
Muscle relaxants (Tolipace SR 450, Tolipace 150)
Topical gels for joint and soft-tissue pain (Palmiwell-NXT)
Gastroenterology & Acid Control
Proton pump inhibitors for reflux and ulcer care
General Medicine & Supplements
Calcium supplements and supportive therapies
5. Biosimilars & Biologics Division
Investing in next-gen therapeutics, this division focuses on:
Monoclonal antibody biosimilars
Recombinant proteins and vaccines
Immunotherapy research
6. Contract Research & Manufacturing Services (CRAMS) Division
DrugsWell partners with global clients to provide turnkey solutions:
Custom API scale-up and GMP manufacturing
Formulation development and process validation
Regulatory filing and technology transfer
Analytical testing (e.g., batch release for Rejubion CD3 batches)
7. Research & Development Division
Innovation is our cornerstone, with programs spanning:
New chemical entity discovery
Novel drug-delivery platforms
Bioavailability enhancement (e.g., optimized Palmiwell-NXT gel formulation)
Collaborative projects with leading academic and clinical centers
8. Quality & Regulatory Affairs Division
Ensuring safety and efficacy across every product:
FDA, WHO-GMP, and ISO compliance audits
Batch-level testing and full documentation traceability
Global regulatory submissions and pharmacovigilance
9. Digital Health & Technology Division
Bridging pharma with technology:
E-prescription and telemedicine platforms
Patient adherence and outcome-tracking digital tools
Data-driven analytics for optimized care
Signature Product Highlights
Rejubion QL: Extended-release neuropathic pain capsule
Mirlivert-16: Vertigo & migraine management tablet
Amitrion-25: Low-dose neuropathic pain capsule
Tolipace SR 450 & Tolipace 150: Muscle relaxant tablets
Rejubion Syrup & Rejubion CD3: Neuropathic pain liquid formulations
Emilysis MD: Acute migraine relief tablet
Palmiwell-NXT: Topical pain-relief gel
Through its divisional structure, DrugsWell delivers tailored solutions—from core APIs to advanced therapies—ensuring quality, accessibility, and innovation for healthcare providers and patients alike.